Novartis Oncology Investor Relations Manager Salaries in Boulder | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Investor Relations Manager Salaries in Boulder

The average Novartis Oncology Investor Relations Manager in Boulder earns an estimated $98,004 annually. Novartis Oncology's Investor Relations Manager compensation is $10,700 more than the US average for a Investor Relations Manager.

In Boulder, The Communications Department at Novartis Oncology earns $35,060 more on average than the Business Development Department.

Last updated 3 years ago.

$51k
$64k
$75k
$85k
$114k
$175k
$98,004
Average Compensation
$98,004
avg. base

Investor Relations Manager Salaries at Novartis Oncology

* estimated salary

Compensation at Novartis Oncology by Department

In Boulder, The Communications Department averages $35,060 more than the Business Development Department, and $436 less than the Enterprise Risk Department

Enterprise Risk
$186,276 Avg. total comp.
+$436
Communications
$185,840 Avg. total comp.
Business Development
$150,780 Avg. total comp.
-$35k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Novartis Oncology reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Novartis Oncology reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Novartis Oncology Rate Their Compensation

The majority of Investor Relations Managers at Novartis Oncology believe they're not compensated fairly. 100% of Investor Relations Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company